Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics

The treatment of connective tissue disease (CTD) and CTD-related intractable diseases (CTD-IDs) currently depends on the use of steroid therapy. Approximately 20 years have passed since the approval of infliximab for rheumatoid arthritis in 2003. Since then, several biological therapeutics have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Yoshio, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487282/
https://www.ncbi.nlm.nih.gov/pubmed/34611450
http://dx.doi.org/10.2147/OARRR.S328211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487282/
https://www.ncbi.nlm.nih.gov/pubmed/34611450
http://dx.doi.org/10.2147/OARRR.S328211

Ejemplares similares